ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Lonza plans to spin off its polymer intermediates business via an initial public offering of shares on the Italian stock exchange. The business, which makes maleic anhydride, isophthalic acid, and plasticizers, had sales last year of about $585 million, almost 30% of Lonza's total sales. The Swiss company, focused on pharmaceutical chemicals, has tried to sell the intermediates business in the past.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter